(S1 (S (NP (NP (NN IL-10) (NN Production)) (PP (IN by) (NP (NP (NP (NN Th2)) (CC and) (NP (NN Th17))) (NNS Cells)))) (ADVP (RB Also)) (VP (VBZ Requires) (NP (NP (NP (NN ERK1)) (CC and) (NP (NN ERK2))) (NN Activation)))))
(S1 (S (S (VP (TO To) (VP (VB address) (SBAR (IN whether) (S (NP (NP (NN IL-10) (NN production)) (PP (IN by) (NP (NP (NP (NN Th2)) (CC and) (NP (NN Th17))) (NNS cells)))) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ dependent) (PP (IN on) (NP (NP (NP (NN ERK1)) (CC and) (NP (NN ERK2))) (NN activation)))))))))) (, ,) (NP (PRP we)) (VP (VBD differentiated) (NP (NP (DT these) (NNS cells)) (PP (IN with) (NP (NP (NN anti-CD3)) (CC and) (NP (NN anti-CD28))))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (NNS APCs)) (PRN (-LRB- -LRB-) (NP (NP (NNP Shoemaker) (FW et) (FW al.) (, ,) (NP (NN 2006))) (: ;) (NP (NNP Veldhoen) (FW et) (FW al.) (, ,) (CD 2009))) (: ;) (NP (NNP Veldhoen) (FW et) (FW al.)) (, ,) (NP (NN 2006)) (-RRB- -RRB-)))))) (, ,) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NP (DT the) (NN MEK) (NN inhibitor)) (PRN (-LRB- -LRB-) (NP (NN PD184352)) (-RRB- -RRB-))))))) (. .)))
(S1 (S (NP (PRP We)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NP (NN ERK1)) (CC and) (NP (NN ERK2))) (NN activation)) (VP (VBZ is) (NP (NP (DT a) (JJ common) (NN pathway)) (VP (VBN required) (PP (IN for) (NP (NP (NN induction)) (PP (IN of) (NP (NN IL-10))) (PP (IN in) (NP (JJ different) (NN Th) (NN cell) (NNS subsets))))))) (SBAR (IN because) (S (NP (NP (NN IL-10) (NN production)) (PP (IN by) (NP (NP (CC both) (NP (NN Th2)) (CC and) (NP (NN Th17))) (NNS cells)))) (VP (VBD was) (ADVP (RB markedly)) (VP (VBN inhibited) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NP (DT the) (NN MEK) (NN inhibitor)) (PRN (-LRB- -LRB-) (NP (NN PD184352)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (CD 5D)) (CC and) (NP (NN Figure) (NN S5B))) (-RRB- -RRB-)))))))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NNS inhibitors)) (PP (PP (IN of) (NP (NN p38) (NN MAPK))) (CC or) (PP (IN of) (NP (NN GSK-3beta) (NN activation))))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN IL-10))) (PP (IN by) (NP (NP (DT these) (NNS subsets)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN S5B)) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (NP (DT the) (NP (NN ERK1)) (CC and) (NP (NN ERK2))) (NN signaling) (NN pathway)))) (VP (VBZ is) (ADVP (RB therefore)) (NP (NP (DT a) (JJ common) (NN requirement)) (PP (IN for) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN IL-10) (NN production))) (PP (IN by) (NP (NP (NN Th1)) (, ,) (NP (NN Th2)) (, ,) (CC and) (NP (NN Th17) (NNS cells))))))))) (. .)))
